Life Saving Drugs Program – Gaucher disease (type 1) – Guidelines

These guidelines contain the general, initial and ongoing eligibility requirements to access certain medications for Gaucher disease (type 1) under the Life Saving Drugs Program.

Downloads

Life Saving Drugs Program – Gaucher disease (type 1) – Guidelines

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Last updated:
Publication type:
Guideline
Audience:
Health sector
Language:
English
Description:

These guidelines include:

  • General information about the Life Saving Drugs Program (LSDP)
  • Treatment of Gaucher disease through the LSDP
  • Drugs currently available for the treatment of Gaucher disease through the LSDP
  • Choice of treatment
  • Dosage
  • Home infusion
  • General, initial and ongoing eligibility requirements
  • LSDP funding conditions
  • Exclusion criteria.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.